For example,overcoming the myocardial-specific delivery bottleneck is essential forcGAS-STING targeted therapy: Existing inhibitors (e.g., C-176) administeredsystemically readily interfere with immune surveillance functions, potentiallyincreasing the risk of infection. Here, STING1 is linked to infection.